Compare PAVM & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAVM | OXBR |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3M | 11.0M |
| IPO Year | 2016 | 2014 |
| Metric | PAVM | OXBR |
|---|---|---|
| Price | $0.32 | $1.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $17.00 | $5.00 |
| AVG Volume (30 Days) | ★ 423.0K | 17.3K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $29,000.00 | ★ $2,423,000.00 |
| Revenue This Year | N/A | $497.99 |
| Revenue Next Year | $450.56 | $42.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.30 | $1.12 |
| 52 Week High | $0.90 | $5.81 |
| Indicator | PAVM | OXBR |
|---|---|---|
| Relative Strength Index (RSI) | 40.95 | 46.86 |
| Support Level | $0.32 | $1.38 |
| Resistance Level | $0.37 | $1.48 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 6.23 | 41.46 |
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.